Dong Wang: Clinical Trials

2 trials sponsored by Dong Wang, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2
Phase 31Unknown 1

Follow Dong Wang: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CIETAI and Sequential Radiotherapy in Squamous Lung Cancer
bronchial artery interventional therapy, Chemotherapy drug, IMRT - Carcinoma, Non-Small-Cell Lung
Phase 2UnknownDong Wang502023-07-012023-08-23
Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors
albumin-bound paclitaxel + oxaliplatin - Advanced Hepatobiliary and Malignant Tumors
Phase 2 / Phase 3UnknownDong Wang572019-08-202019-08-19

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Neoplasms (1)

Interventions

Albumin-Bound Paclitaxel (1)  ·  Immunotherapy (1)  ·  Oxaliplatin (1)

Countries

China (1)